- CFO Spotlights
- Profiles
- Aaron Bloomer
Profile
Aaron Bloomer
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer), ResMed |
In the seat. First published here October 28, 2026; built from records as of October 28, 2026.
Aaron Bloomer signed the annual report of ResMed | as Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer); the report was filed on August 13, 2026, the most recent filing in the record that ties Aaron Bloomer to the seat.1
Seats
The seat in the record
| Company | Title as filed | Standing |
|---|---|---|
| ResMed | (RMD) Surgical & Medical Instruments & Apparatus | Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | In the seat |
Company names link to the company's page in the record at CFO Tribune, which holds the seat history.
The record
Filing by filing, latest first
- August 13, 202610-K filed
Aaron Bloomer signed the annual report of ResMed | on Form 10-K as Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer), filed August 13, 2026.
/S/ AARON BLOOMER Chief Financial Officer August 13, 2026 Aaron Bloomer (Principal Financial Officer and Principal Accounting Officer)
[1] Annual report on Form 10-K by ResMed |, filed with the SEC on August 13, 2026. Read the filing. The record at CFO Tribune.
Sources
Sources
- Annual report on Form 10-K, ResMed |. U.S. Securities and Exchange Commission, EDGAR, filed August 13, 2026. sec.gov; record.
Corrections and removal
If a line here is wrong, or Aaron Bloomer wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.